During the past decade, Southampton National Institute for Health Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southampton National Institute for Health Research" are "Malaria" (2 trials). Many other conditions were trialed in "Southampton National Institute for Health Research" in a lesser frequency.

Most popular intervention types in "Southampton National Institute for Health Research" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "ChAd63 ME-TRAP" (1 trials), "ChAd63 ME-TRAP and MVA ME-TRAP vaccination" (1 trials), "MVA ME-TRAP" (1 trials) and "R21 with Matrix-M1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southampton National Institute for Health Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Southampton National Institute for Health Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Southampton National Institute for Health Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southampton National Institute for Health Research, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".